Literature DB >> 15617514

Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.

Mercy O Quagraine1, Fulong Tan, Hironori Tamei, Ervin G Erdös, Randal A Skidgel.   

Abstract

Human CPN (carboxypeptidase N) is a tetrameric plasma enzyme containing two glycosylated 83 kDa non-catalytic/regulatory subunits that carry and protect two active catalytic subunits. Because CPN can regulate the level of plasminogen binding to cell surface proteins, we investigated how plasmin cleaves CPN and the consequences. The products of hydrolysis were analysed by activity assays, Western blotting, gel filtration and sequencing. When incubated with intact CPN tetramer, plasmin rapidly cleaved the 83 kDa subunit at the Arg457-Ser458 bond near the C-terminus to produce fragments of 72 and 13 kDa, thereby releasing an active 142 kDa heterodimer, and also cleaved the active subunit, decreasing its size from 55 kDa to 48 kDa. Further evidence for the heterodimeric form of CPN was obtained by re-complexing the non-catalytic 72 kDa fragment with recombinant catalytic subunit or by immunoprecipitation of the catalytic subunit after plasmin treatment of CPN using an antibody specific for the 83 kDa subunit. Upon longer incubation, plasmin cleaved the catalytic subunit at Arg218-Arg219 to generate fragments of 27 kDa and 21 kDa, held together by non-covalent bonds, that were more active than the native enzyme. These data show that plasmin can alter CPN structure and activity, and that the C-terminal 13 kDa fragment of the CPN 83 kDa subunit is a docking peptide that is necessary to maintain the stable active tetrameric form of human CPN in plasma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617514      PMCID: PMC1186696          DOI: 10.1042/BJ20041471

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

Review 1.  Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties.

Authors:  J Vendrell; E Querol; F X Avilés
Journal:  Biochim Biophys Acta       Date:  2000-03-07

2.  Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily.

Authors:  F X Gomis-Rüth; V Companys; Y Qian; L D Fricker; J Vendrell; F X Avilés; M Coll
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

Review 3.  Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.

Authors:  C F Mojcik; J H Levy
Journal:  Ann Thorac Surg       Date:  2001-02       Impact factor: 4.330

Review 4.  The thrombolytic paradox.

Authors:  H M Hoffmeister; S Szabo; U Helber; L Seipel
Journal:  Thromb Res       Date:  2001-09-30       Impact factor: 3.944

5.  Human carboxypeptidase N: lysine carboxypeptidase.

Authors:  R A Skidgel
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Probable reversal of protamine reactions by heparin administration.

Authors:  R Lock; E A Hessel
Journal:  J Cardiothorac Anesth       Date:  1990-10

7.  cDNA cloning and complete primary structure of the small, active subunit of human carboxypeptidase N (kininase 1).

Authors:  W Gebhard; M Schube; M Eulitz
Journal:  Eur J Biochem       Date:  1989-01-02

Review 8.  Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.

Authors:  M Nesheim; W Wang; M Boffa; M Nagashima; J Morser; L Bajzar
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

9.  Effect of mutation of two critical glutamic acid residues on the activity and stability of human carboxypeptidase M and characterization of its signal for glycosylphosphatidylinositol anchoring.

Authors:  Fulong Tan; Scott Balsitis; Judy K Black; Andrea Blöchl; Ji-Fang Mao; Robert P Becker; David Schacht; Randal A Skidgel
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

10.  Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency.

Authors:  K P Mathews; J G Curd; T E Hugli
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

View more
  2 in total

Review 1.  Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.

Authors:  Randal A Skidgel; Ervin G Erdös
Journal:  Int Immunopharmacol       Date:  2007-08-15       Impact factor: 4.932

2.  Proteomics-Based Approach to Identify Novel Blood Biomarker Candidates for Differentiating Intracerebral Hemorrhage From Ischemic Stroke-A Pilot Study.

Authors:  David Malicek; Ilka Wittig; Sebastian Luger; Christian Foerch
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.